I had posted yesterday regarding the developing story of Roche attempting to takeover Illumina. I was looking at the website of Roche and came across some interesting information. The concept of personalized healthcare is relatively new and a lot of research is being carried in this regard. Roche heavily invests in biotechnology and it has invested over 8 billion Swiss francs in 2011 in research and development. Regarding the concept of Personalized Healthcare, the following video throws some light over it.
Investors see these developments and progress as signals regarding the future performance of the company. These sentiments are seen in the price of stock and the investors behaviour in terms of going long on stocks. The attempt of acquiring Illumina is a move in progressing towards Personalized Healthcare.